ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Physician Assistant, Medical

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,636Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 49

$602K Total Retail Price of All Prescriptions

Rank: 3 out of 49

606 Patients Receiving at Least One Drug in Part D
91% Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Louisiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 606 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $76 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 7.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 324 319* 72 1 4
OMEPRAZOLE 305 290 63 2 2
AMLODIPINE BESYLATE 279 274* 57 3 1
HYDROCODONE-ACETAMINOPHEN 271 245 97 S3 4 6
SIMVASTATIN 265 232 55 5 9
CITALOPRAM HBR 241 224 59 6 32
FUROSEMIDE 223 218* 65 7 9
ALPRAZOLAM 200 174 71 B 8 35
ATENOLOL 176 161 28 9 19
DONEPEZIL HCL 176 171* 32 9 36
NAMENDA 172 167* 38 11 39
CLOPIDOGREL 151 146* 24 12 13
ESCITALOPRAM OXALATE 149 144* 36 13 48
HYDROCHLOROTHIAZIDE 146 129 28 14 12
LISINOPRIL 145 140* 32 15 3
METOPROLOL SUCCINATE 137 124 27 16 14
GABAPENTIN 134 129* 27 17 7
METHYLPREDNISOLONE 134 129* 100 17 41
BENAZEPRIL HCL 128 123* 18 19 26
SERTRALINE HCL 128 123* 28 19 33
METFORMIN HCL 124 108 34 21 5
NEXIUM 114 97 25 22 18
LEVOFLOXACIN 110 105* 89 23 63
METOPROLOL TARTRATE 109 109 23 24 16
MELOXICAM 109 104* 22 24 15
GLIMEPIRIDE 103 98* 25 26 29
QUETIAPINE FUMARATE 100 87 16 A 27 73
MIRTAZAPINE 91 86* 20 28 78
TRAZODONE HCL 89 84* 27 29 52
LOSARTAN POTASSIUM 83 83 16 30 27
AMLODIPINE BESYLATE-BENAZEPRIL 81 <11 <11 31 47
WARFARIN SODIUM 78 78 16 32 30
AZITHROMYCIN 77 72* 71 33 24
TRAMADOL HCL 74 69* 34 34 17
CRESTOR 69 64* 14 35 20
NAPROXEN 68 63* 24 36 87
CARVEDILOL 67 54 14 37 20
PANTOPRAZOLE SODIUM 63 58* 15 38 62
TEMAZEPAM 62 62 12 B 39 94
POTASSIUM CHLORIDE 62 57* 19 39 23
DIOVAN 61 47 12 41 60
DIGOX 58 58 12 42 44
CLONIDINE HCL 58 <11 <11 42 40
CYMBALTA 57 57 12 44 66
FLUTICASONE PROPIONATE 57 52* 27 44 58
ATORVASTATIN CALCIUM 57 52* 18 44 8
CELEBREX 57 46 12 44 60
LORAZEPAM 55 55 18 B 48 102
TRIAMCINOLONE ACETONIDE 54 54 39 49 43
ADVAIR DISKUS 54 49* 14 49 105
EXELON 53 48* 12 51 109
RISPERIDONE 50 <11 <11 A 52 113
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.